Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatab (Q46670307)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatab |
scientific article published in September 2005 |
Statements
1 reference
Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatab (English)
1 reference
Yoshimasa Aso
1 reference
Sadao Wakabayashi
1 reference
Ruriko Yamamoto
1 reference
Rika Matsutomo
1 reference
Kohzo Takebayashi
1 reference
Toshihiko Inukai
1 reference
1 September 2005
1 reference
1 reference
28
1 reference
9
1 reference
2211-2216
1 reference
Identifiers
1 reference
1 reference